MedTrace Logo

Effects of Oral L-Arginine on Chronic Hypertension in Pregnancy

NCT00571766 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-09-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of oral L-Arginine in pregnant women with chronic hypertension.

Conditions

  • Hypertension in Pregnancy

Interventions

DRUG

L-Arginine

Oral L-Arginine 2g, twice a day for 14 weeks

DRUG

Placebo

Placebo 2 g twice a day for 14 weeks

Sponsors & Collaborators

  • University of Modena and Reggio Emilia

    lead OTHER

Principal Investigators

  • Fabio Facchinetti, MD · University of Modena and Reggio Emilia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00571766 on ClinicalTrials.gov